MENU

BOLT Bolt Biotherapeutics Inc Forecast, Technical & Fundamental Analysis

Bolt Biotherapeutics Inc is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer... Show more

BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
View a ticker or compare two or three
BOLT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

BOLT is expected to report earnings to fall 22.74% to -332 cents per share on August 12

Bolt Biotherapeutics Inc BOLT Stock Earnings Reports
Q2'26
Est.
$-3.33
Q1'26
Missed
by $3.95
Q4'25
Missed
by $3.54
Q3'25
Missed
by $3.42
Q2'25
Missed
by $4.15
The last earnings report on May 12 showed earnings per share of -430 cents, missing the estimate of -36 cents. With 3.53K shares outstanding, the current market capitalization sits at 7.26M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
900 Chesapeake Drive
Phone
+1 650 665-9295
Employees
23
Web
https://www.boltbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RNG42.050.28
+0.67%
RINGCENTRAL
CANF3.260.01
+0.31%
Can-Fite Biopharma Ltd
FFIV420.95-9.44
-2.19%
F5, Inc.
KOPN3.63-0.27
-6.92%
Kopin Corp
WBX4.94-0.43
-8.01%
Wallbox NV

BOLT and Stocks

Correlation & Price change

A.I.dvisor tells us that BOLT and NRXP have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BOLT and NRXP's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BOLT
1D Price
Change %
BOLT100%
-5.97%
NRXP - BOLT
31%
Poorly correlated
+1.95%
XENE - BOLT
31%
Poorly correlated
-2.87%
ARRY - BOLT
30%
Poorly correlated
-1.39%
KRRO - BOLT
29%
Poorly correlated
+1.82%
SPRO - BOLT
28%
Poorly correlated
-0.94%
More
Bolt Biotherapeutics (BOLT) stock Forecast, Price Targets and Analysts Predictions - Tickeron.com